TGF-β is up-regulated and activated in fibrotic diseases, and it is capable of inducing pulmonary fibrosis through the stimulation of both classical and non-classical signalling pathways, which triggers the activation of myofibroblasts and the overexpression of the extracellular matrix. This evidence concerns the gene TGFB1 and pulmonary fibrosis.